Valuation: CORESTEMCHEMON Inc.

Market Cap 88.5B 63.86M 54.7M 51.18M 46.85M 87.93M 6.11B 89.09M 605M 236M 3.07B 240M 235M 10.15B P/E 2024
-3.45x
P/E 2025 -2.05x
Enterprise Value 119B 86.05M 73.71M 68.97M 63.13M 118M 8.23B 120M 815M 318M 4.14B 323M 316M 13.68B EV / Sales 2024
4.76x
EV / Sales 2025 5.59x
Free-Float
81.23%
Yield 2024 *
-
Yield 2025 -
1 day-0.99%
1 week-8.28%
Current month+10.28%
1 month+8.07%
3 months-46.73%
6 months-42.34%
Current year+7.95%
1 week 1,920
Extreme 1920
2,175
1 month 1,642
Extreme 1642
2,390
Current year 1,642
Extreme 1642
6,100
1 year 1,014
Extreme 1014
6,100
3 years 1,014
Extreme 1014
15,610
5 years 1,014
Extreme 1014
24,450
10 years 1,014
Extreme 1014
34,350
Manager TitleAgeSince
Chief Executive Officer 70 -
President 54 -
President 65 2000-07-31
Director TitleAgeSince
Director/Board Member 61 2015-06-15
Director/Board Member 65 2000-07-31
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
5/2/25 Sell

Chief Technology Officer

64,262 0.1955%
5/2/25 Sell

Chairperson

151,072 0.4596%
10/7/24 Others 1,875 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-8.28%-9.11%-69.77% 63.86M
-1.05%+3.67%+2.51%+22.97% 51.61B
-1.07%+2.82%+465.96%+570.70% 44.89B
+1.47%+9.79%+35.92%+20.21% 42.77B
+1.44%+7.77%+19.38%+84.65% 42.58B
-0.93%-4.33%+16.18%+55.82% 31.82B
+1.32%+7.30%+33.89%+148.53% 17.33B
-0.60%+1.93% - - 16.63B
+0.16%+4.23%+9.32%+30.33% 14.76B
+1.28%+5.41%+82.40%+46.13% 14.09B
Average +0.10%+3.16%+72.94%+101.06% 27.65B
Weighted average by Cap. +0.09%+4.71%+99.31%+141.28%

Financials

2024 2025
Net sales 28.76B 20.75M 17.78M 16.63M 15.23M 28.58M 1.99B 28.95M 197M 76.64M 998M 77.93M 76.23M 3.3B 20.16B 14.55M 12.46M 11.66M 10.67M 20.03M 1.39B 20.29M 138M 53.71M 699M 54.62M 53.43M 2.31B
Net income -26.25B -18.94M -16.23M -15.18M -13.9M -26.08M -1.81B -26.43M -179M -69.95M -910M -71.13M -69.58M -3.01B -26.83B -19.36M -16.59M -15.52M -14.21M -26.66M -1.85B -27.01M -183M -71.5M -931M -72.7M -71.12M -3.08B
Net Debt 42.32B 30.54M 26.16M 24.48M 22.41M 42.05M 2.92B 42.61M 289M 113M 1.47B 115M 112M 4.86B 30.76B 22.19M 19.01M 17.79M 16.28M 30.56M 2.12B 30.96M 210M 81.96M 1.07B 83.34M 81.52M 3.53B
Logo CORESTEMCHEMON Inc.
Corestemchemon Inc, formerly Corestem Inc, is a Korea-based company engaged in the development, production and sale of stem cell therapies for intractable diseases. The Company operates its business through two segments. The Non-clinical Contract Research Organization (CRO) Business segment is engaged in the provision of research and development services such as toxicity (safety) verification and drug efficacy (efficacy) verification in the non-clinical stage. The Cell Therapy Business segment is engaged in the development, production and sale of Lou Gehrig's disease treatments such as Neuronata-R.
Employees
36
Date Price Change Volume
26-08-21 ₩1,995.00 -0.99% 91,893
26-08-20 ₩2,015.00 +2.81% 45,789
26-08-19 ₩1,960.00 -2.00% 86,640
26-08-18 ₩2,000.00 -8.05% 164,927
  1. Stock Market
  2. Stocks
  3. A166480 Stock